David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$708M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$614M |
| 3 |
Merck
MRK
|
+$521M |
| 4 |
Bank of America
BAC
|
+$492M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$646M |
| 2 |
Tesla
TSLA
|
+$607M |
| 3 |
Microsoft
MSFT
|
+$491M |
| 4 |
Accenture
ACN
|
+$482M |
| 5 |
Broadcom
AVGO
|
+$438M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.84% |
| 2 | Consumer Discretionary | 9.28% |
| 3 | Healthcare | 6.84% |
| 4 | Financials | 6.63% |
| 5 | Industrials | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
PUT
MakeMyTrip
MMYT
$5.68B
| $288K | ﹤0.01% |
3,100
+400
| +15% | +$37.7K |
|
3852
CALL
Blue Bird Corp
BLBD
$1.86B
| $288K | ﹤0.01% |
+6,000
| New | +$296K |
|
3853
CALL
HEICO Corp
HEI
$49.1B
| $288K | ﹤0.01% |
+1,100
| New | +$266K |
|
3854
Newmark Group
NMRK
$2.9B
| $287K | ﹤0.01% |
18,506
-102,403
| -85% | -$1.33M |
|
3855
SLR Investment Corp
SLRC
$687M
| $287K | ﹤0.01% |
+19,080
| New | +$297K |
|
3856
EPR Properties
EPR
$4.62B
| $287K | ﹤0.01% |
5,849
+1,042
| +22% | +$47.6K |
|
|
ENFN
3857
DELISTED
Enfusion, Inc.
ENFN
| $287K | ﹤0.01% |
30,222
+16,840
| +126% | +$145K |
|
3858
Energy Fuels
UUUU
$3.99B
| $286K | ﹤0.01% |
+52,066
| New | +$271K |
|
3859
Southern First Bancshares
SFST
$588M
| $282K | ﹤0.01% |
8,277
+200
| +2% | +$6.44K |
|
3860
Wheaton Precious Metals
WPM
$74.4B
| $281K | ﹤0.01% |
+4,600
| New | +$274K |
|
3861
Magnite
MGNI
$3.43B
| $281K | ﹤0.01% |
20,270
-20,827
| -51% | -$284K |
|
3862
PUT
Neogen
NEOG
$2.54B
| $281K | ﹤0.01% |
16,700
| – | – |
|
3863
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.79B
| $281K | ﹤0.01% |
+3,433
| New | +$270K |
|
|
BFS
3864
Saul Centers
BFS
$844M
| $280K | ﹤0.01% |
6,664
-5,228
| -44% | -$206K |
|
|
NVRO
3865
PUT
DELISTED
NEVRO CORP.
NVRO
| $280K | ﹤0.01% |
50,000
-57,000
| -53% | -$399K |
|
3866
iShares International Select Dividend ETF
IDV
$8.7B
| $279K | ﹤0.01% |
+9,217
| New | +$268K |
|
3867
iShares MSCI Spain ETF
EWP
$2.27B
| $276K | ﹤0.01% |
+7,829
| New | +$259K |
|
3868
PUT
Vulcan Materials
VMC
$35.5B
| $275K | ﹤0.01% |
+1,100
| New | +$273K |
|
3869
SiTime
SITM
$17.9B
| $275K | ﹤0.01% |
1,604
-746
| -32% | -$107K |
|
3870
Piper Sandler
PIPR
$5.28B
| $275K | ﹤0.01% |
+3,872
| New | +$253K |
|
3871
PUT
iRhythm Holdings
IRTC
$4.06B
| $275K | ﹤0.01% |
+3,700
| New | +$295K |
|
3872
CALL
Inspire Medical Systems
INSP
$1.77B
| $274K | ﹤0.01% |
+1,300
| New | +$226K |
|
3873
Zymeworks
ZYME
$1.96B
| $273K | ﹤0.01% |
21,782
-21,974
| -50% | -$239K |
|
|
DFSV
3874
Dimensional US Small Cap Value ETF
DFSV
$8.33B
| $273K | ﹤0.01% |
8,860
-73,536
| -89% | -$2.2M |
|
3875
WisdomTree US Quality Growth Fund
QGRW
$2.92B
| $273K | ﹤0.01% |
+5,978
| New | +$264K |
|
Similar funds
David Shaw's Q3 2024 Portfolio in Review
As of Q3 2024, David Shaw held 5,052 positions worth $116B, up 8.9% from $107B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2024 filing shows 599 new, 1,568 increased, 1,742 reduced and 558 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,429,800 shares worth $115M. The largest sale was Adobe, an estimated $646M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q3 2024 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,429,800 shares worth $115M.
- David Shaw added most to NVIDIA in Q3 2024, an estimated $708M increase.
- David Shaw's biggest Q3 2024 reduction was Adobe, cutting an estimated $646M.
- David Shaw fully exited WestRock Company in Q3 2024, selling an estimated $148M.
- David Shaw's ten largest holdings make up 9.6% of its $116B portfolio in Q3 2024.
- David Shaw opened 599 new positions and closed 558 in Q3 2024.
- David Shaw's portfolio value rose 8.9% quarter-over-quarter to $116B.
Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.